References
- WilliamsRAireyMBaxterHForresterJKennedy-MartinTGirachAEpidemiology of diabetic retinopathy and macular oedema: a systematic reviewEye (Lond)2004181096398315232600
- DanaeiGFinucaneMMLuYGlobal Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose)National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participantsLancet20113789785314021705069
- KleinRKleinBEMossSELintonKLThe Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitusOphthalmology199299158621741141
- KiniMMLeibowitzHMColtonTNickersonRJGanleyJDawberTRPrevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye studyAm J Ophthalmol19788512834619683
- KleinRKleinBEMossSEWongTYThe relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye StudyTrans Am Ophthalmol Soc20061049810717471330
- WongTYLiewGTappRJRelation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studiesLancet2008371961473674318313502
- MitchellPSmithWWangJJAtteboKPrevalence of diabetic retinopathy in an older community. The Blue Mountains Eye StudyOphthalmology199810534064119499768
- MassinPLangeCTichetJDESIR (Data From an Epidemiological Study on the Insulin Resistance Syndrome) Study GroupHemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR studyArch Ophthalmol2011129218819521320965
- ACCORD Study Group, ACCORD Eye Study GroupChewEYEffects of medical therapies on retinopathy progression in type 2 diabetesN Engl J Med2010363323324420587587
- LimLSTaiESMitchellPC-reactive protein, body mass index, and diabetic retinopathyInvest Ophthalmol Vis Sci20105194458446320805569
- CornierMADabeleaDHernandezTLThe metabolic syndromeEndocr Rev200829777782218971485
- AlbertiKGZimmetPShawJMetabolic syndrome – a new worldwide definition. A consensus statement from the international diabetes federationDiabet Med200623546948016681555
- Metascreen Writing CommitteeBonadonnaRCCucinottaDFedeleDRiccardiGTiengoAThe metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from metascreen, a multicenter diabetes clinic-based surveyDiabetes Care200629122701270717130208
- GuzderRNGatlingWMulleeMAByrneCDImpact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetesDiabetologia2006491495516341841
- SongSHHardistyCADiagnosing metabolic syndrome in type 2 diabetes: does it matter?QJM2008101648749118353792
- WeissRDziuraJBurgertTSObesity and the metabolic syndrome in children and adolescentsN Engl J Med2004350232362237415175438
- CameronAJMaglianoDJZimmetPZWelbornTShawJEThe metabolic syndrome in Australia: prevalence using four definitionsDiabetes Res Clin Pract200777347147817350710
- CullCAJensenCCRetnakaranRHolmanRRImpact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78Circulation2007116192119212617967769
- CostaLACananiLHLisboaHRTresGSGrossJLAggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetesDiabet Med200421325225515008835
- Abdul-GhaniMNawafGNawafFItzhakBMinuchinOVardiPIncreased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndromeIsr Med Assoc J20068637838216833164
- IsomaaBHenricssonMAlmgrenPTuomiTTaskinenMRGroopLThe metabolic syndrome influences the risk of chronic complications in patients with type II diabetesDiabetologia20014491148115411596670
- RamanRGuptaAPalSSPrevalence of metabolic syndrome and its influence on microvascular complications in the Indian population with type 2 diabetes mellitusSankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 14)Diabetol Metab Syndr201026721067623
- ZhangXSaaddineJBChouCFPrevalence of diabetic retinopathy in the United States, 2005–2008JAMA2010304664965620699456
- EckelRHGrundySMZimmetPZThe metabolic syndromeLancet200536594681415142815836891
- ChatziralliIPSergentanisTNKeryttopoulosPVatkalisNAgorastosAPapazisisLRisk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2BMC Res Notes2010315320515457
- RaniPKRamanRChandrakantanAPalSSPerumalGMSharmaTRisk factors for diabetic retinopathy in self-reported rural population with diabetesJ Postgrad Med2009552929619550052
- WangSXuLJonasJBMajor eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye StudyOphthalmology2009116122373238019815279
- RobertsCKSindhuKKOxidative stress and metabolic syndromeLife Sci20098421–2270571219281826
- KurellaMLoJCChertowGMMetabolic syndrome and the risk for chronic kidney disease among nondiabetic adultsJ Am Soc Nephrol20051672134214015901764
- SagunGKantarciGMesciBFrequency of cardiovascular risk factors and metabolic syndrome in patients with chronic kidney diseaseClin Med Res201083–413514120682757